ADHD Medication in Australia: Strattera to Be Added
It was just reported today in Australia, that the non-stimulant medicine Strattera (Atomoxetine) will be funded under the Pharmaceutical Benefits Scheme, starting July 1, 2007.
Prior to this, the only options covered under the plan are stimulant medicines.
Strattera is the first non-stimulant indicated for ADHD. In Canada and the USA, it is indicated in the treatment of ADD/ADHD in children aged 6 and older, teens, as well as adults with the disorder.
To read more about the story in Australia, visit here.
To read more about Strattera, visit here: Strattera for ADHD.
=================================================
Written by Dr. Kenny Handelman - The ADHD Doctor
To find get a FREE special report on ADD/ADHD Medication, visit: Medication Mastery
==================================================
Email this post to a friend:








April 24th, 2007 at 3:13 am
As an adult with ADHD (in Australia), I looked into Strattera.
I was amazed at the number of men reporting issues related to urine flow, ejaculatory pain, prostate, etc.
No way in heck am I going near that drug.
If you or others doubt me just google “strattera ejaculation” or similar.
This link also summarises some issues that should trouble people a little:
http://perth.indymedia.org/?action=newswire&parentview=55068
Cheers,
- Alister
July 31st, 2008 at 3:35 pm
Hi,
I’m doing an ADHD research paper, and am trying to find which provinces long acting meds are approved in. Can’t find it anywhere? Any chance you would know? You are the ADD Doctor after all!
Thanks,
Mark Witten
August 2nd, 2008 at 8:18 pm
When the heck is Australia getting Adderall and Vyvanse?
August 4th, 2008 at 4:39 pm
Hi,
I’m sorry to say that i don’t know the answer to that.
I believe that Australia has dexedrine, which is very similar to adderall and vyvanse - though not 100% the same.
When I know, I’ll share it with you
Best,
Dr. Kenny
August 27th, 2008 at 1:30 am
Dexamphetamine is one isomer or structural form, Adderall contains two isomers, one a mirror image of the other. In Australia, roadside testing of drivers for drug intoxication or usage has been adopted almost universally. It can discriminate between dex and its laevo mirror image. Adderall contains the laevo isomer and will be picked up by all the drug testing kits presently in use. Unless someone comes up with a test that can separate the laevo isomer from methamphetamine and street concoctions, there will never be a commercially available, legal source of Adderall.
Vyvanse is a different kettle of fish, the only thing holding it back is the need for the manufacturer to apply to the Therapeutic Goods Administration in Australia to authorise its use. This process can take from 2 to 5 years or more, depending on the strength of the supporting research and documentation and also whether the manufacturer thinks that they will get a return on their investment of the costs of registration.